Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,261 to 1,280 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion. | Cancer Res | 2021 | 34610968 | PubTator, text mining | PubMed |
| Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study. | Clin Cancer Res | 2021 | 34598946 | PubTator, text mining | PubMed |
| The Protexin complex counters resection on stalled forks to promote homologous recombination and crosslink repair. | Mol Cell | 2021 | 34597596 | PubTator, text mining | PubMed |
| Lipid Droplet-Organelle Contact Sites as Hubs for Fatty Acid Metabolism, Trafficking, and Metabolic Channeling. | Front Cell Dev Biol | 2021 | 34595176 | PubTator, text mining | PubMed |
| High-Grade Neuroendocrine Carcinoma Within a Tracheal Polyp: A Case Report. | JTO Clin Res Rep | 2021 | 34590020 | PubTator, text mining | PubMed |
| Differentially expressed genes in Alzheimer's disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1. | Brain Behav Immun Health | 2021 | 34589742 | PubTator, text mining | PubMed |
| B4GALNT2 Gene Promotes Proliferation, and Invasiveness and Migration Abilities of Model Triple Negative Breast Cancer (TNBC) Cells by Interacting With HLA-B Protein. | Front Oncol | 2021 | 34589428 | PubTator, text mining | PubMed |
| A comprehensive molecular study identified 12 complementation groups with 56 novel FANC gene variants in Indian Fanconi anemia subjects. | Hum Mutat | 2021 | 34585473 | PubTator, text mining | PubMed |
| Copper Film Modified Glassy Carbon Electrode and Copper Film with Carbon Nanotubes Modified Screen-Printed Electrode for the Cd(II) Determination. | Materials (Basel) | 2021 | 34576372 | PubTator, text mining | PubMed |
| Serum Albumin: A Multifaced Enzyme. | Int J Mol Sci | 2021 | 34576249 | PubTator, text mining | PubMed |
| Identification of Arvicola terrestris scherman Sperm Antigens for Immune Contraceptive Purposes. | Int J Mol Sci | 2021 | 34576131 | PubTator, text mining | PubMed |
| Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the Clinic. | Int J Mol Sci | 2021 | 34575947 | PubTator, text mining | PubMed |
| Oxidative Stress, Mutations and Chromosomal Aberrations Induced by In Vitro and In Vivo Exposure to Furan. | Int J Mol Sci | 2021 | 34575853 | PubTator, text mining | PubMed |
| Clonal Evolution of Multiple Myeloma-Clinical and Diagnostic Implications. | Diagnostics (Basel) | 2021 | 34573876 | PubTator, text mining | PubMed |
| Determinants of Homologous Recombination Deficiency in Pancreatic Cancer. | Cancers (Basel) | 2021 | 34572943 | PubTator, text mining | PubMed |
| PARP Inhibitors in Melanoma-An Expanding Therapeutic Option? | Cancers (Basel) | 2021 | 34572747 | PubTator, text mining | PubMed |
| Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC). | Biomedicines | 2021 | 34572433 | PubTator, text mining | PubMed |
| Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening. | Cells | 2021 | 34571968 | PubTator, text mining | PubMed |
| Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection. | Onco Targets Ther | 2021 | 34552338 | PubTator, text mining | PubMed |
| A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer. | Nat Commun | 2021 | 34552099 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=64